![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/505 | |
A61K 31/506 | |||
A61K 45/06 | |||
A61P 35/00 | |||
A61P 35/02 |
(11) | Number of the document | 3280795 |
(13) | Kind of document | T |
(96) | European patent application number | 16718786.3 |
Date of filing the European patent application | 2016-04-07 | |
(97) | Date of publication of the European application | 2018-02-14 |
(45) | Date of publication and mention of the grant of the patent | 2021-03-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/026437 |
Date | 2016-04-07 |
(87) | Number | WO 2016/164580 |
Date | 2016-10-13 |
(30) | Number | Date | Country code |
201562144188 P | 2015-04-07 | US |
(72) |
BYRD, John, US
DUBOVSKY, Jason, US
JOHNSON, Amy, US
JUNE, Carl, H., US
MUTHUSAMY, Natarajan, US
PORTER, David, L., US
WASIK, Mariusz, US
ANGST, Daniela, CH
FRAIETTA, Joseph, A., US
GESSIER, Francois, CH
GILL, Saar, US
MAUS, Marcela, US
RUELLA, Marco, US
VULPETTI, Anna, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
The Trustees of The University of Pennsylvania, 3160 Chestnut Street Suite 200, Philadelphia, PA 19104, US |
(54) | COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES |
COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES |